This application seeks renewal of an Institutional Postdoctoral Training Grant (HL07914) in the area of """"""""Vascular Biology and Pathology"""""""" at the Cleveland Clinic Foundation (CCF). In its prior iteration, the training program provided support for 5 postdoctoral fellows annually, and the faculty consisted of 7 members within two CCF Research Departments. Eleven postdoctoral fellows were supported;all remain actively engaged in research;and 7 former trainees now hold faculty positions in academic institutions. The current proposal requests continuing support for training postdoctoral fellows within vascular biology, an area of major growth and need for competent new investigators in an area of major biomedical importance. In recognition of the growing demands in the field, in addition to continuing to train basic researchers, the renewal application has been expanded to provide translational research training focus. The faculty has been expanded to 11 members and now includes members of 4 departments;Molecular Cardiology, Cell Biology, Cardiology and Vascular Surgery. With vascular biology remaining the theme that unifies the research interests of the faculty, the following specific topics are emphasized: 1) vascular cell biology;2) receptor functions on vascular cells;3) risk factors for cardiovascular disease (CVD);4) atherosclerosis and thrombosis;and 5) translational research in CVD. Fellows will have opportunities for projects involving basic and/or clinical research and will participate in activities sponsored by the grant that will lead to an understanding and appreciation of the broad spectrum of research activities CVD. In addition, the training grant mentors, co- mentors and CCF provide opportunities for trainees to learn skills important for their career development. The institution also provides Fellows with access to cutting-edge technologies through a diverse array of core services and extensive seminar programs for Fellows to learn from outside investigators and to hone their own presentation skills. The application also requests support for short-term training of four, second year medical school students to support their clinical research experience in the newly created Cleveland Clinic Lerner College of Medicine. This short-term training provides a tangible approach to interest future physician-scientists with a commitment (a mandatory 5 year program) to research to focus on CVD. Overall, the combination of experienced mentors conducting cutting-edge research, the commitment of CCF and CCLCM to research and education, and the framework of this grant should provide an exceptional training environment for both postdoctoral fellows and medical students to build successful careers in research in vascular biology and pathology.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
5T32HL007914-10
Application #
8046394
Study Section
Special Emphasis Panel (ZHL1-CSR-J (F1))
Program Officer
Chang, Henry
Project Start
1999-07-01
Project End
2014-03-31
Budget Start
2011-04-01
Budget End
2014-03-31
Support Year
10
Fiscal Year
2011
Total Cost
$298,454
Indirect Cost
Name
Cleveland Clinic Lerner
Department
Other Basic Sciences
Type
Schools of Medicine
DUNS #
135781701
City
Cleveland
State
OH
Country
United States
Zip Code
44195
Takezako, Takanobu; Unal, Hamiyet; Karnik, Sadashiva S et al. (2018) The non-biphenyl-tetrazole angiotensin AT1 receptor antagonist eprosartan is a unique and robust inverse agonist of the active state of the AT1 receptor. Br J Pharmacol 175:2454-2469
Hannibal, Luciana; Page, Richard C; Haque, Mohammad Mahfuzul et al. (2015) Dissecting structural and electronic effects in inducible nitric oxide synthase. Biochem J 467:153-65
Zhang, Haitao; Unal, Hamiyet; Gati, Cornelius et al. (2015) Structure of the Angiotensin receptor revealed by serial femtosecond crystallography. Cell 161:833-44
Zhang, Haitao; Unal, Hamiyet; Desnoyer, Russell et al. (2015) Structural Basis for Ligand Recognition and Functional Selectivity at Angiotensin Receptor. J Biol Chem 290:29127-39
Brown, Paul M; Kennedy, David J; Morton, Richard E et al. (2015) CD36/SR-B2-TLR2 Dependent Pathways Enhance Porphyromonas gingivalis Mediated Atherosclerosis in the Ldlr KO Mouse Model. PLoS One 10:e0125126
Zhang, Huaqun; Amick, Joseph; Chakravarti, Ritu et al. (2015) A bipartite interaction between Hsp70 and CHIP regulates ubiquitination of chaperoned client proteins. Structure 23:472-482
Takezako, Takanobu; Unal, Hamiyet; Karnik, Sadashiva S et al. (2015) Structure-Function Basis of Attenuated Inverse Agonism of Angiotensin II Type 1 Receptor Blockers for Active-State Angiotensin II Type 1 Receptor. Mol Pharmacol 88:488-501
Sossey-Alaoui, Khalid; Pluskota, Elzbieta; Davuluri, Gangarao et al. (2014) Kindlin-3 enhances breast cancer progression and metastasis by activating Twist-mediated angiogenesis. FASEB J 28:2260-71
Unal, Hamiyet; Karnik, Sadashiva S (2014) Constitutive activity in the angiotensin II type 1 receptor: discovery and applications. Adv Pharmacol 70:155-74
Amick, Joseph; Schlanger, Simon E; Wachnowsky, Christine et al. (2014) Crystal structure of the nucleotide-binding domain of mortalin, the mitochondrial Hsp70 chaperone. Protein Sci 23:833-42

Showing the most recent 10 out of 47 publications